Article CommentaryCommentaire

Innocuité des β2-agonistes dans la prise en charge de l’asthme

Un point de vue de la Primary Care Respiratory Alliance of Canada

Anthony D. D’Urzo, Pieter Jugovic, Jacques Bouchard, Reuven Jhirad and Itamar Tamari
Canadian Family Physician February 2010; 56 (2) 123-124;
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Respond to this article
Innocuité des β2-agonistes dans la prise en charge de l’asthme
Anthony D. D’Urzo, Pieter Jugovic, Jacques Bouchard, Reuven Jhirad, Itamar Tamari
Canadian Family Physician Feb 2010, 56 (2) 123-124;
Twitter logo Facebook logo Mendeley logo

Jump to section

Subjects